Edition:
United States

Orion Oyj (ORNBV.HE)

ORNBV.HE on Helsinki Stock Exchange

30.23EUR
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
€30.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
548,496
52-wk High
€42.52
52-wk Low
€22.57

Chart for

About

Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical... (more)

Overall

Beta: 0.76
Market Cap(Mil.): €4,272.82
Shares Outstanding(Mil.): 141.26
Dividend: 1.45
Yield (%): 4.80

Financials

  ORNBV.HE Industry Sector
P/E (TTM): 21.09 28.29 30.45
EPS (TTM): 1.43 -- --
ROI: 26.80 12.92 12.63
ROE: 32.19 14.94 14.82

BRIEF-Orion Oyj to sell its Orion Diagnostica division

* REG-ORION TO SELL ITS ORION DIAGNOSTICA DIVISION - DUE TO THE TRANSACTION ORION UPDATES ITS OUTLOOK

Apr 20 2018

BRIEF-Orion Updates Primary Completion Date Of Phase III To September 2018

* STATUS UPDATE OF THE PHASE III ARAMIS CLINICAL TRIAL WITH DAROLUTAMIDE IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Apr 03 2018

BRIEF-Orion: Positive Conclusions For Salmeterol-Fluticasone Easyhaler Combination Under EU's Decentralized Procedures

* ORION HAS RECEIVED POSITIVE CONCLUSIONS FOR THE SALMETEROL-FLUTICASONE EASYHALER® COMBINATION UNDER THE EU'S DECENTRALIZED PROCEDURES

Mar 19 2018

BRIEF-Orion Conducts Personnel Reduction of 17 Positions

* ‍17 PERSONS OF COMPANY'S PERSONNEL WILL BE GIVEN A NOTICE.​

Feb 28 2018

Earnings vs. Estimates